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As an intrinsically disordered protein, monomeric alpha-synuclein (aSyn) occupies a large
conformational space. Certain conformations lead to aggregation prone and non-aggregation
prone intermediates, but identifying these within the dynamic ensemble of monomeric
conformations is difficult. Herein, we used the biologically relevant calcium ion to investigate
the conformation of monomeric aSyn in relation to its aggregation propensity. We observe
that the more exposed the N-terminus and the beginning of the NAC region of aSyn are, the
more aggregation prone monomeric aSyn conformations become. Solvent exposure of the N-
terminus of aSyn occurs upon release of C-terminus interactions when calcium binds, but the
level of exposure and aSyn’s aggregation propensity is sequence and post translational
modification dependent. Identifying aggregation prone conformations of monomeric aSyn and
the environmental conditions they form under will allow us to design new therapeutics
targeted to the monomeric protein.
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In Parkinson’s disease (PD) and other synucleinopathies, themonomeric protein alpha-synuclein (aSyn) becomes destabi-lised, misfolds and aggregates into insoluble, highly structured
and β-sheet containing fibrils which form part of Lewy bodies
(LB) and Lewy neurites (LN)1,2. In its monomeric form, the
14.46 kDa aSyn is a soluble, intrinsically disordered protein (IDP)
that is highly flexible and thereby enables plasticity in its function.
In particular, it has been proposed that aSyn plays a role in
synaptic vesicle recycling and homeostasis in neurons3,4. Tran-
sient and dynamic electrostatic and hydrophobic intramolecular
interactions maintain aSyn in its soluble monomeric form. These
intramolecular interactions are responsible for aSyn’s smaller
radius of gyration (Rg) than expected for a 140 residue fully
unfolded protein and suggest that some residual structure
remains5. Therefore, the word ‘monomer’ actually describes a
plethora of conformational states which are constantly reconfi-
guring. These dynamic interactions are heavily influenced by the
surrounding environment of aSyn and their disruption can
lead to skewing of the ensemble of monomeric conformations6.
This, in turn, may influence which aggregation competent/
incompetent pathways are taken and whether these are subse-
quently toxic or not. Identifying conformations of aggregation
prone monomeric aSyn or the environment that can destabilise
monomeric conformations to favour aggregation will aid in the
design of anti-aggregation therapeutics to stabilise the native aSyn
conformation.
aSyn is a characteristic IDP with high opposing charge at its
termini and low overall hydrophobicity5. Monomeric aSyn has
three characteristic main regions; the N-terminus, residues 1–60,
which is overall positively charged, the non-amyloid-β compo-
nent (NAC) region 61–95, which is hydrophobic and forms the
core of fibrils during aggregation7, and the C-terminus, residues
96–140, is a highly negatively charged region which binds metal
ions8 (Fig. 1a). To date, six disease-related mutations have been
identified in the SNCA gene, encoding the aSyn protein, A30P,
E46K, H50Q, G51D, A53T, A53E, which are a hallmark for
hereditary autosomal dominant PD and are primarily linked to
early age, but also late age of onset (H50Q)9–15. However, genetic
mutations and multiplications of the SNCA gene and other PD-
associated genes only account for 5–10% of PD cases and the
remaining cases are sporadic (idiopathic) and age-related16. Yet,
we still have not identified mechanistically why these mutations
lead to early-onset PD, or what triggers misfolding of wild-type
(WT) aSyn.
Intramolecular long-range interactions of aSyn have been
detected between many different regions of aSyn. Electrostatic
interactions, mediated by the positively charged N-terminus and
negatively charged C-terminus, as well as hydrophobic interac-
tions between some residues of the C-terminus and NAC region
of aSyn, have been identified using a range of techniques
including different nuclear magnetic resonance (NMR) techni-
ques, mass spectrometry (MS) and hydrogen-deuterium exchange
MS (HDX-MS)6,17–25 (Fig. 1b). The importance of these long-
range interactions was demonstrated in studies in which charge
and hydrophobicity of the protein were altered by mutations,
particularly at the C-terminus, leading to differences in the
aggregation propensity of aSyn26–29. Reduction of charge also
occurs during the binding of metal ions, salt ions or polyamines
which leads to shielding of the charged N- and C-termini and
which permits more energetically favourable packing into
fibrils8,30.
Furthermore, post-translational modifications (PTM), such as
nitration and phosphorylation, also alter aggregation rates of
aSyn. In particular, phosphorylation of S129 which increases the
negative charge of the C-terminus by the addition of a PO42−
group seems to be pertinent in disease as only 4% of monomeric
aSyn is phosphorylated, yet 96% of aSyn in LB and LN are
phosphorylated31. However, it is not clear whether phosphor-
ylation of S129 is involved in the physiological or pathological
function of aSyn, whether it enhances aggregation32,33 or retards
aggregation34. In terms of disease association, the presence of
aSyn familial mutations leads to different aggregation rates
dependent on the mutation. NMR experiments have shown that
C-terminus residues are transiently in contact with all six
mutation sites at the N-terminus via long-range interactions23,
yet the different mutations lead to differences in levels of solvent
exposure, destabilisation, perturbation of the ensemble of con-
formers and alterations in long-range interactions35–38. Identi-
fying conformations or significant long-range interactions that
maintain soluble aSyn is critical in understanding what triggers
aSyn misfolding, but the difficulty in identifying these long-range
interactions and determining the influence of mutations and
aggregation prone conformations of aSyn lies in the complexity of
sampling an ensemble of dynamic conformations of the mono-
meric protein.
In the current study, we apply a plethora of techniques,
including NMR, HDX-MS, and native nano electrospray ionisa-
tion (ESI) MS to study the differences in the conformation of
aggregation prone and non-aggregation prone monomeric aSyn
including phosphorylated aSyn, pS129, and familial aSyn
mutants, A30P, E46K, H50Q, G51D, A53T and A53E. To
investigate potential differences in residual structure and long-
range interactions, we also performed experiments in the pre-
sence of calcium to purposefully skew the dynamic ensemble of
conformations as calcium binds at the C-terminus and leads to
charge neutralisation39. Calcium has been shown to play a role in
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Fig. 1 Representation of the regions of monomeric aSyn. a Monomeric
aSyn is defined by three regions, the N-terminus, residues 1–60 (blue) with
an overall charge of +4, contains the familial mutations A30P, E46K,
H50Q, G51D, A53E and A53T. The non-Amyloid-β component (NAC)
region, residues 61–95 (yellow), has an overall charge of −1, is highly
hydrophobic and forms the core of fibrils. The C-terminus, residues 96–140
(red), is highly negatively charged with an overall charge of −12. Residue
S129 is commonly phosphorylated (pS129) in Lewy bodies, but rarely in its
soluble state. The calcium binding region (black line) is also found at the C-
terminus and spans residues 115–140. b Monomeric aSyn is highly dynamic
and visits a large conformational space. Transient intramolecular
interactions between the N-terminus (blue) and C-terminus (red) and NAC
region (yellow) maintain it in a soluble form. Created with BioRender.com.
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the physiological and pathological function of aSyn, as calcium
binding at the C-terminus of aSyn facilitates interaction with
synaptic vesicles and enhances aSyn aggregation rates8,40. Fur-
thermore, calcium-aSyn interaction is physiologically relevant as
calcium buffering becomes dysregulated in PD and an increase in
cytosolic calcium occurs41. We therefore also investigated a panel
of C-terminus mutants D115A, D119A and D121A which are
within the calcium binding region40.
We conclude that the perturbation of long-range interactions
upon calcium binding to monomeric aSyn leads to an increase in
N-terminus solvent exposure for some aSyn variants which cor-
relates with their increased aggregation propensity. The extent of
N-terminus exposure is influenced by the presence of different
PTMs and familial mutations, where the distribution of mono-
meric conformations of the aSyn ensemble is different between
the aSyn variants. The finding that different structural con-
formations can be identified as early as at the monomer level will
be crucial in aiding the development of aSyn aggregation inhi-
bitors stabilising native non-aggregation prone structures.
Results
pS129 and D121A have altered conformations compared to
WT aSyn. We first investigated whether interactions mediated by
the C-terminus of aSyn were important in modulating monomer
conformation and aggregation propensity. We compared WT
aSyn to post-translationally modified aSyn, phosphorylated at
residue serine 129 (pS129), which increases the C-terminus
negative charge, and to a mutant with reduced charge by
mutating aspartate (D) to alanine (A) at residue 121 (D121A).
The D121A aSyn mutant was chosen from a panel of C-terminus
D to A mutants, 115, 119 and 121, which reside in the region of
divalent and trivalent cation binding sites8,42. D121A aSyn was
chosen for further investigation as it displayed a decreased
aggregation rate using a thioflavin-T (ThT) based kinetic assay
compared to D115A, D119A and WT aSyn (Supplementary
Figs. 1–2, Supplementary Note 1).
We first compared the conformation of monomeric D121A
and pS129 aSyn to WT aSyn using 1H-15N heteronuclear single
quantum correlation (HSQC) spectra in solution. In comparison
to WT aSyn there are chemical shift perturbations (CSPs) around
the location of the D121A mutation and around the phosphory-
lated S129 residue, but otherwise no clear CSPs in the N-terminus
and NAC regions (Fig. 2a, Supplementary Fig. 3).
As CSPs of D121A and pS129 aSyn compared to WT aSyn
were relatively small aside from the mutation/phosphorylation
sites, we next investigated whether addition of calcium could
skew the heterogeneous conformational ensemble of monomeric
aSyn leading to more homogeneous calcium bound structures
which may indicate differences in the structure of the three
monomeric aSyn more clearly. Binding of calcium alters
electrostatic interactions as it neutralises the negative charge at
the C-terminus of aSyn8. We performed a calcium titration from
0.2–4.2 mM and observed significant CSPs at the C-terminus
for all three aSyn samples (using a fixed protein concentration
of 200 μM), as shown previously for WT aSyn (Fig. 2b,
Supplementary Fig. 4)40. To show that C-terminus CSPs observed
in the above experiment are due to a direct interaction of calcium
and aSyn and not simply due to global electrostatic effects, we
also performed NMR experiments in the presence of 4 mM NaCl.
The results in Supplementary Fig. 5 show that we observed no
specific C-terminus CSPs. For D121A aSyn, in addition to the
main CSPs at the calcium binding region, we observe higher CSPs
across the region of residues 1–100 when compared to WT and
pS129 aSyn, which is significant as a point mutation usually alters
primarily a very localised region of the sequence in a disordered
protein43 (Fig. 2b, green). Furthermore, we previously observed
broadening of the NAC region for WT aSyn when calcium was
bound40, yet we observe no broadening in D121A aSyn (Fig. 2c,
Supplementary Fig. 6), suggesting that interactions with the NAC
region were altered in D121A aSyn. Our data further indicate that
pS129 aSyn also has altered long range interactions in
comparison to WT aSyn. Firstly, there appear to be more
localised C-terminus CSPs upon calcium binding compared to
D121A and WT aSyn (Fig. 2b, yellow). Residues involved in metal
binding have previously been shown to be altered upon
phosphorylation42. Secondly, as observed for D121A aSyn, there
was no broadening of the NAC region when calcium was bound
(Fig. 2c, Supplementary Fig. 7). These alterations in CSPs upon
calcium binding suggest that long range interactions of pS129 and
D121A aSyn are already altered compared to WT aSyn which
may have implications in terms of the aggregation propensity of
these aSyn variants both in the absence and presence of calcium.
In order to determine whether the above structural changes we
had observed in the presence of calcium were simply due to
changes in the affinity for calcium of the different aSyn variants,
we determined the dissociation constant using two different
fitting algorithms from the titration experiments. Using a
previously applied model44, but this time using a fixed ligand
(calcium) number of 3, we obtained a KD of 95 (±16) μM, 91
(±16) μM and 69 (±8) μM for WT, pS129 and D121A aSyn,
respectively. Using the Hill equation, which also takes into
account the level of cooperativity, we obtain a KD of 670 (±50)
μM, 670 (±30) μM and 460 (±30) μM for WT, pS129 and D121A
aSyn, respectively. For all fittings, we get an n > 1, indicating that
calcium binds cooperatively to aSyn (Supplementary Fig. 8).
We next performed ThT-based kinetic assays to investigate
whether the above observed conformational differences or
calcium binding capacities of aSyn influenced the aggregation
propensity of the three aSyn variants. Upon binding to β-sheet
rich fibrillary structures the molecule ThT emits fluorescence
which provides a read out for the kinetics of aSyn aggregation.
The results of the assay showed that although D121A and pS129
aSyn had different charges at the C-terminus, both had a lower
aggregation propensity than WT aSyn, particularly in the absence
of calcium (Supplementary Fig. 9). The presence of calcium
increased the aggregation rate of D121A and pS129 aSyn in
comparison to aggregation rates without calcium, however not to
the same extent as the rate of WT aSyn. This was also reflected in
the concentration of remaining monomer determined by size-
exclusion chromatography using high-pressure liquid chromato-
graphy (SEC-HPLC) (Supplementary Figs. 9 and 10). It appears
that the affinity of aSyn to calcium does not influence aggregation
rate per se as the affinity of D121A aSyn for calcium is higher
than of WT and pS129 aSyn. We hypothesised that changes in the
monomeric long-range interactions may influence aggregation
propensity and explain the differences we had observed.
D121A and pS129 aSyn are less exposed at the N-terminus. We
further investigated whether the perturbations observed by NMR
led to region specific shielding or exposure of D121A and pS129
aSyn monomers using HDX-MS. This technique probes the
submolecular structure and dynamics of proteins by employing
hydrogen-deuterium exchange, and thus permits the identifica-
tion of protein sequences that are more exposed to the solvent
and/or less strongly hydrogen-bonded (deprotected) at physio-
logical pH. Binary comparison of the deuterium uptake profile
between WT and D121A aSyn and WT and pS129 aSyn showed
that both variants are not significantly different to WT aSyn in
terms of exposure (Fig. 3a, b, Supplementary Tables 1 and 2), but
this technique may not yet be sensitive enough to determine
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Fig. 2 1H-15N spectra of WT, D121A and pS129 aSyn indicate conformational differences. a We compared chemical shift perturbations in the amide
backbone of 1H-15N D121A aSyn to WT aSyn (green) and pS129 aSyn to WT aSyn (yellow) in 20mM Tris pH 7.2 (using a fixed protein concentration of
200 μM) and observed CSPs around the location of the D to A mutation and the PO42− of S129 at the C-terminus (for the full zoomed out spectrum see
Supplementary Fig. 3.). (b) Significant CSPs were observed at the C-terminus upon addition of 4.2 mM calcium for all, WT (blue), D121A (green) and pS129
(yellow) aSyn. (Titration data for all concentrations of calcium are available in Supplementary Fig. 4). Higher CSPs are observed for D121A compared to WT
and pS129 aSyn. c 1H-15N HSQC NMR spectra of pS129 and D121A aSyn in the absence (red) and in the presence of calcium (green) (Supplementary Figs. 6
and 7 show spectra with more labels). Major CSPs in the presence of calcium are located at the C-terminus (arrows with assigned amino acid residues) in
both pS129 and D121A aSyn.
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changes in the ensemble of conformations as it is an averaging
measurement technique.
We again used calcium to perturb the ensemble of conforma-
tions in order to compare alterations of long-range interactions
between the three aSyn variants. Binary comparison of the
deuterium uptake profile of monomeric WT aSyn revealed
solvent protection at the C-terminus and significant deprotection
at the NAC and the N-terminus region of aSyn in the presence of
calcium compared to the absence of calcium (Fig. 3c,
Supplementary Table 3). This indicates that, when calcium is
bound to aSyn, there is reduced exposure to the solvent or
increased hydrogen bonding at the C-terminus of aSyn, where
calcium binds, as observed by CSPs using NMR, and deprotection
of the N-terminus and NAC region. A similar behaviour was
observed for D121A and pS129 aSyn as, upon calcium binding,
solvent protection at the C-terminus and deprotection at the
NAC region of aSyn (Fig. 3d, e, Supplementary Tables 4 and 5).
However, while D121A aSyn has a solvent exposed N-terminus,
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pS129 aSyn displays little difference in protection levels at the N-
terminus. Yet. both D121A and pS129 aSyn, have a more
protected/less exposed N-terminus compared to WT aSyn in the
calcium-bound state in these averaging measurement data
(Fig. 3c–e). Both NMR and HDX-MS indicate that D121A and
pS129 aSyn have a different ensemble of conformations compared
to WT aSyn. We observe a correlation between the exposure of
the N-terminus, which is much less pronounced in D121A and
pS129 aSyn than in WT aSyn, with a reduced aggregation
propensity in the calcium-bound state, as determined by the ThT
fluorescence kinetic assay. This highlights the strength of our
approach to determine conformational changes already in
monomeric aSyn.
Aggregation propensity correlates with N-terminus exposure.
To further investigate whether differences in the sub-molecular
structure are apparent in the familial aSyn mutants A30P, E46K,
H50Q, G51D, A53T and A53E and whether this can influence
aggregation rates, we first studied their aggregation kinetics in the
presence and absence of calcium using ThT-based kinetic assays.
Comparison of the fibrillisation rates of the familial mutants with
WT aSyn in the absence of calcium shows that the aSyn mutants
A53T, E46K, and H50Q aggregate faster than WT aSyn while the
familial aSyn mutants A30P, A53E, and G51D aggregate more
slowly than WT aSyn (Fig. 4a, c–e, plate repeats are shown in
Supplementary Fig. 12a). Upon the addition of calcium, WT aSyn
nucleation and elongation is enhanced, as previously shown40,
and for the fast aggregating aSyn mutants, A53T, E46K, and
H50Q the aggregation rate is also enhanced upon the addition of
calcium, similarly to WT aSyn. However, the slow aggregating
aSyn mutants A30P, A53E, and G51D are either insensitive to
calcium addition or aggregate more slowly (Fig. 4b–e, plate
repeats are shown in Supplementary Fig. 12b).
We next performed native nano ESI-MS to determine whether
differences in the number of calcium ions bound to each aSyn
mutant could result in differences in the aSyn aggregation rate.
There were no significant differences in the number of calcium
ions bound to any of the aSyn mutants, with on average two to
three Ca2+ ions bound at a 1:10 protein to calcium ratio, and up
to 10 ions at high (1:250) calcium concentrations (Fig. 5,
Supplementary Figs. 13–15). We also performed native nano
ESI-IM-MS in an attempt to resolve heterogeneous structures in
the ensemble of aSyn conformations which was not possible with
either NMR or HDX-MS. The ion mobility of a protein is
determined by the number of collisions the protein ions have with
gas molecules, influencing the drift (or arrival) time which is a
direct correlation to the rotationally averaged size and shape of
the particle. This technique may permit us to determine whether
there is a change in the distribution of conformations between
different aSyn mutants. In the gas-phase, WT aSyn was found to
have four main conformational distributions at the 8+ charge
state which have been observed previously45–47, however, there
were no clear alterations in the distribution of conformations
between the mutants and WT aSyn in the presence or absence of
calcium or at other charge states. This is discussed further in
Supplementary Note 2 (Supplementary Figs. 16–18, Supplemen-
tary Tables 6 and 7).
To gain more detailed and localised structural information of
the monomeric aSyn mutants we again employed HDX-MS. The
familial aSyn mutants A53T and A53E were selected from the
familial mutants’ panel for this analysis, as they displayed
different aggregation behaviour, with faster aggregation rates for
A53T and slower aggregation rates for A53E, even though the
point mutations are at the same residue. Binary comparison of
WT and A53T aSyn (Fig. 6a, Supplementary Table 8), WT and
A53E aSyn (Fig. 6b, Supplementary Table 9) and A53T and A53E
aSyn (Fig. 6c, Supplementary Table 10) in the absence of calcium
showed that there was no significant difference in deuterium
uptake between the two compared protein states. Upon the
addition of calcium, solvent protection is observed at the C-
terminus of A53T and A53E aSyn, similar to WT and the other
aSyn variants (see D121A and pS129 aSyn), indicating that the
protection at this region is primarily due to calcium binding. At
the same time, A53T aSyn is significantly deprotected at the N-
terminus, at a similar level to WT aSyn, indicating a breaking of
hydrogen bonding or a local unfolding event (Fig. 6d, e,
Supplementary Table 11). In contrast, for A53E aSyn (Fig. 6f,
Supplementary Table 12) there are mostly no significant
differences at the NAC region or at the N-terminus (with the
exception of peptides 55–89 and 55–94), upon calcium binding.
Thus, the extent to which structural dynamics are perturbed in
the N-terminal region in response to binding of calcium at the C-
terminus correlates with an increase in the aggregation propensity
of aSyn and its variants.
Discussion
As an intrinsically disordered protein, aSyn is constantly sam-
pling a large conformational space and exists as an ensemble of
conformations. The distribution of these conformations is sig-
nificantly influenced by both changes in the sequence of the
protein (e.g. mutations or PTMs) and the surrounding environ-
ment. Some of these structural conformers are expected to follow
different aggregation pathways, possibly resulting in different
fibril polymorphs and even leading to different disease outcomes.
By understanding how genetic and environmental factors, such as
mutations, PTMs and calcium, influence the dynamics of con-
formation and favour monomeric aggregation-prone structures,
we may begin to understand the initiation of misfolding pathways
leading to different synucleinopathies, and subsequently how to
disrupt them. However, here within lies the difficulty as the
Fig. 3 HDX-MS reveals different conformations of D121A and pS129 compared to WT aSyn. Bars represent differences in deuterium uptake of peptides
along the sequence of differently compared aSyn variants (e.g. WT vs D121A aSyn) with the N-terminus region in blue, the NAC region in yellow, and the
C-terminus of aSyn in red. Negative values represent increased deuterium uptake in the variant (a, b) or in the calcium bound state (c–e), correlating to
more solvent exposure, and less hydrogen bonding. The start and end of each peptide is marked on the x-axis (see aSyn peptide map in Supplementary
Fig. 11). Peptides containing the mutation were not comparable to WT aSyn and were removed from the data set, indicated by blank regions. Comparison of
the deuterium uptake (in Dalton -Da) between a WT and D121A aSyn and b WT and pS129 aSyn showed no significant differences to WT aSyn. c In the
presence of calcium, WT aSyn becomes significantly more deprotected (more solvent exposed/less hydrogen bonded) at the N-terminus and the NAC
region, and at the same time becomes solvent protected at the C-terminus. d D121A aSyn is significantly more deprotected at the N-terminus and the NAC
region upon calcium addition and solvent protected at the C-terminus. e pS129 aSyn is deprotected at the NAC region upon calcium addition and solvent
protected at the C-terminus, while no significant differences were observed at the N-terminus. The grey dashed line signifies the error (1 s.d.) of six
replicates collected per condition. Data acquired at each peptide were subjected to an unpaired Student’s t-test with alpha set to 1%. Each row was
analysed individually, without assuming a consistent SD, individual two-tailed p values are presented in Supplementary Tables 1–5 and significant
differences where p-values are ≤0.01 are presented by a *. Individual replicate values for deuterium uptake are presented in Supplementary Figs. 22–24.
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conformations that monomeric aSyn samples are similar in size,
charge and structure and are thus hard to detect using ensemble
measurement techniques. Furthermore, the presence of a familial
mutation does not appear to significantly alter the conformation
compared to WT aSyn as observed by these techniques. In this
study, we used the biologically relevant ion, calcium, to perturb
the conformational ensemble of aSyn structures and compared
the differences in CSPs and hydrogen bonding/solvent exposure
between aSyn and its mutants. Calcium has been shown to
enhance the aggregation rate of WT aSyn40,48, likely by a similar
mechanism as low pH, whereby the reduction of the negative
charge at the C-terminus leads to C-terminal collapse when
100a
Fl
uo
re
sc
en
ce
 (%
 of
 m
ax
)
80
60
40
20
0
0 50 100
Time (h)
150
WT
A30P
A53T
E46K
A53E
G51D
H50Q
0 50 100
Time (h)
150
100
Fl
uo
re
sc
en
ce
 (%
 of
 m
ax
)
80
60
40
20
0
200
t la
g 
(ho
urs
)
150
100
25
7
35
13
20 18
30
11
37 40 34
67
92
135
50
0
WT A5
3T
E4
6K
H5
0Q
WT
 + 
Ca
2+
A5
3T
 + 
Ca
2+
E4
6K
 + 
Ca
2+
H5
0Q
 + 
Ca
2+
A3
0P
 + 
Ca
2+
A5
3E
A5
3E
 + 
Ca
2+
G5
1D
 + 
Ca
2+
G5
1D
A3
0P
WT A5
3T
E4
6K
H5
0Q
WT
 + 
Ca
2+
A5
3T
 + 
Ca
2+
E4
6K
 + 
Ca
2+
H5
0Q
 + 
Ca
2+
A3
0P
 + 
Ca
2+
A5
3E
A5
3E
 + 
Ca
2+
A3
0P
WT A5
3T
E4
6K
H5
0Q
WT
 + 
Ca
2+
A5
3T
 + 
Ca
2+
E4
6K
 + 
Ca
2+
H5
0Q
 + 
Ca
2+
A3
0P
 + 
Ca
2+
A5
3E
A5
3E
 + 
Ca
2+
G5
1D
 + 
Ca
2+
G5
1D
A3
0P
t 5
0 
(ho
urs
)
150
100
50
0
20
R
em
ai
ni
ng
 m
on
om
er
 (μ
M
)
15
10
5
0
59
19
57
34 43
24
61
16
53 53
69
96
4.2
1.9
5.8
5.0
5.3
2.3 7.5
6.3
5.5 5.8
5.4 5.9
9.8 8.9
c
d
e
b
WT + Ca
A30P + Ca
A53T + Ca
E46K + Ca
A53E + Ca
G51D + Ca
H50Q + Ca
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-16564-3 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:2820 | https://doi.org/10.1038/s41467-020-16564-3 | www.nature.com/naturecommunications 7
electrostatic repulsion is reduced, leading to altered long-range
electrostatic interactions and enhanced hydrophobic interaction
between the C-terminus and the NAC region which drives
aggregation22,49–52. We observed mutant specific differences in
long-range interactions, compaction and solvent exposure com-
pared to WT aSyn which correlate to aggregation propensity and
will be discussed individually.
We first investigated the role of charge and long-range inter-
actions at the C-terminus by comparing two aSyn variants with
reduced (D121A) and added (pS129) negative charge. We
observed that both D121A and pS129 aSyn displayed reduced
aggregation rates in comparison to WT aSyn, indicating that
increasing or decreasing charge by one residue at the C-terminus
does not decrease or increase aggregation rates, respectively, as it
may have been expected. We observe that calcium binding affi-
nity does not correlate with aggregation rates, suggesting that
aggregation rates are not altered by a single residue charge or
calcium binding per se. Furthermore, our results show that there
is positive cooperativity for calcium binding to aSyn, which
indicates that charge and electrostatic interactions are not the
driving force for calcium binding, as this would lead to negative
cooperativity. We argue that calcium binding leads to a con-
formational change, which consequently leads to a positive
cooperativity. This subsequent conformational change and the
extent of the altered conformation governs aggregation pro-
pensity. KD predictions of intrinsically disordered proteins are
known to be challenging, in particular as calcium binding to aSyn
does not lead to a characteristic conformation-induced protein-
ligand binding. The highly dynamic nature of monomeric aSyn
may not permit defined calcium binding structures to be formed,
making it difficult to extract an exact KD value. This may explain
why the two fitting models vary in their KD predictions.
We only observed small differences in the conformational
properties of monomeric aSyn, as revealed by changes in CSPs
and solvent exposure compared to WT aSyn in the absence of
calcium for D121A or pS129 aSyn. This is likely due to the vast
array of conformations sampled by the protein leading to mini-
mal structural changes using averaging measurement techniques
such as NMR and HDX-MS. However, by perturbing the
ensemble of conformations, as seen upon the addition of calcium,
we could observe differences in CSPs and deuterium uptake upon
calcium binding. By NMR, we observe pS129 aSyn has a different
calcium-binding region and displays no broadening in the NAC
region compared to WT aSyn, while D121A has a higher degree
of CSPs across the sequence, but also no NAC region broadening,
suggesting long-range interactions with the NAC region in both
these variants are altered before calcium binds. Broadening in the
NAC region has been observed for WT aSyn when bound to
calcium40 and at low pH, suggesting enhanced interactions
between the charge neutralised calcium binding C-terminus and
the NAC region22.
Regarding aSyn’s propensity to aggregate, we observe, using
HDX-MS, that the N-terminus of pS129 aSyn is not solvent
exposed upon calcium binding, whereas for D121A aSyn,
although the N-terminus is slightly exposed, is significantly less
exposed compared to WT aSyn upon calcium binding, which is
correlated with the decreased aggregation propensity of both
D121A and pS129 aSyn. Previous HDX-MS studies have
Fig. 4 ThT-based aggregation assays reveal different aggregation behaviour for aSyn familial mutants. Aggregation kinetics of aSyn WT and familial
mutants A30P, A53T, E46K, A53E, H50Q, G51D were measured using ThT fluorescence intensity and plotted as % of maximum fluorescence a in
the absence of calcium and b in the presence of 2.5 mM CaCl2 (plate repeat data are available in Supplementary Fig. 12). 20 μM aSyn was incubated with
20 μM ThT in a half area 96 well plate with orbital agitation at 300 rpm for 5 min before each read every hour for 150 h. c Lag time (tlag) and d time to
reach 50% of maximum aggregation (t50) were calculated and the mean is numerically shown (tlag: *p= 0.0145, **p= 0.0034, ***p= 0.001, t50: **p=
0.001, ***p= 0.0003, ***p= 0.0004, *p= 0.043, *p= 0.002)). Mutant G51D did not reach the elongation phase in the studied timeframe, so the t50 value
was not calculated in (c). e The remaining monomer concentration was determined using SEC-HPLC, 35 μL of monomer from each well in the ThT assays
was analysed on an AdvanceBio SEC 130 Å column in 20mM Tris pH 7.2 at 1 mLmin−1. Remaining monomer concentrations were measured from the area
under the peak and calculated using a standard curve of known concentrations. The mean remaining monomer concentration is numerically shown (*p=
0.0438, *p= 0.0466). Measurements were repeated using at least four sample replicates in three experiments and an unpaired two-tailed t-test with a
95% confidence interval was used to calculate statistical significance between samples before and after the addition of calcium. Error bars represent s.d.
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suggested that the N-terminus of aSyn may be involved in
aggregation as there is heterogeneity in its solvent exposure
during aggregation, while the C-terminus remains completely
solvent exposed53–56. Yet, we show here that it is the extent of N-
terminus exposure that influences aggregation propensity.
Importantly, for monomeric aSyn we only observe N-terminus
exposure upon disruption of long-range interactions with the C-
terminus upon calcium binding. The C-terminus thus greatly
influences aggregation propensity, as it is important in main-
taining long range interactions and solubility of monomeric
aSyn57,58. Many studies investigating the effect of the C-terminus,
particularly its charge, on aSyn aggregation rates use C-terminus
truncations which heavily disrupt and remove long-range inter-
actions. Instead studying mutations of specific residues gives us
further insight into the importance of sequence defined interac-
tions. For instance mutation of proline59, or glutamate58 residues
to alanine at the C-terminus increases aSyn aggregation pro-
pensity, yet mutation of tyrosine27 residues to alanine decreases
aSyn aggregation propensity. Even phosphorylation of S129
compared to Y125 aSyn (only 4 residues apart) leads to
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differences in aggregation rates, as pY125 does not influence the
aggregation rate when compared to WT aSyn60, while pS129
reduces aggregation rates even in aSyn truncated at Y133 and
D13561. pY125 aSyn also does not have an altered binding
capacity to C-terminus nanobodies nor an altered binding region
of metals as pS129 aSyn does, indicating that there are very site-
specific functions and interactions present at the C-terminus
which warrant further exploration. It further shows that
sequence-specific interactions are important in maintaining long-
range interactions42,60. Although D121A aSyn is not a naturally
occurring mutation, by comparing it to pS129, we can explore
how altering long-range interactions of monomeric aSyn at the
C-terminus by mutation or PTM and variation of the local
environment, e.g. addition of calcium, leads to altered interac-
tions with the NAC region and different levels of solvent exposure
at the N-terminus. Our results highlight that both sequence and
environment are important in determining aSyn’s aggregation
propensity.
While all familial aSyn point mutations reside at the N-ter-
minus, the putative calcium binding site is at the C-terminus62.
Certainly, the presence of a familial aSyn mutation has been
shown to alter interactions between the mutation site and the C-
terminus by NMR compared to WT aSyn, with varying differ-
ences apparent for each aSyn mutant in both physiological and
mildly acidic conditions23,36. The increase in aggregation pro-
pensity of WT aSyn upon calcium binding cannot only be
explained by charge neutralisation at the C-terminus as all
familial aSyn mutants should have responded in the same way to
calcium, instead we observe that the familial aSyn mutants have
different aggregation kinetics. It is more likely that the difference
in aggregation propensity is a result of perturbed long-range
interactions with the C-terminus, which is understandable con-
sidering the mutation regions interact with the calcium binding
regions at the C-terminus. Using HDX-MS, we observe mutant
specific differences in the level of solvent protection at the N-
terminus of A53T and A53E aSyn upon binding of calcium
suggesting that indeed different long-range interactions are pre-
sent. A local unfolding event (deprotection) at the N-terminus
and the NAC region of WT and A53T aSyn correlates with their
increased aggregation propensity upon calcium addition. No such
deprotection was observed for the aSyn mutant A53E, where no
significant differences where observed upon calcium binding,
except for two small peptides, and whose aggregation kinetics
were, firstly slower than both WT and A53T aSyn, but also had
similar kinetics in the presence and absence of calcium. In
another study, the ‘fast aggregating’ mutant, E46K, also displays
an increased solvent exposure across its sequence, and in addi-
tion, N-terminus residues of E46K aSyn are involved in oligo-
merisation36. We expect that the release of long-range contacts
with the C-terminus leads to exposure of the N-terminus and the
NAC region, observed in WT and A53T aSyn, to be a major
factor influencing aSyn aggregation kinetics. Previous experi-
ments have shown that the N-terminus of aSyn may modulate
aSyn aggregation; altering sequence, cross-linking specific resi-
dues and targeting binding proteins to the N-terminus leads to
variation in aggregation kinetics63–68. Previous studies have
shown mutant aSyn have altered long-range interactions com-
pared to WT aSyn35,69–72. Our study suggests that the altered
stability at the N-terminus combined with mutant aSyn’s lower
propensity to form an α-helix compared to WT aSyn, may skew
the distribution of the conformational ensemble leading to con-
formations with a high propensity to form oligomers and fibrils.
The fact that such differences in aSyn long-range contacts and an
increase in N-terminus solvent exposure can be identified as early
as at the monomer level, and correlate to the propensity to
fibrillise is important, and a step towards understanding early
events in the misfolding pathway and how structure and envir-
onmental factors may influence aggregation propensity of the
monomer. Interestingly the N-terminus and NAC region of aSyn
have also been implicated in the formation of phase separated
aSyn73. It remains to be determined whether the structure of the
initial monomer subsequently influences the tertiary structural
fate of aSyn or influences fibril structure.
As an IDP, aSyn samples many different conformations mak-
ing it difficult to identify specific aggregation prone conforma-
tions, particularly using ensemble measurement techniques. By
comparing the submolecular structure of calcium-bound aSyn
variants, we instead sampled a skewed population and inferred
differences in structure and aggregation propensity as part of a
response to calcium binding at the monomer level. We attribute
the increase in aggregation propensity upon calcium binding to
structural perturbation, as we observe no correlation in aSyn’s
aggregation propensity to its affinity to calcium, the number of
calcium ions bound or charge neutralisation at the C-terminus.
Instead, we observe different responses to calcium based on the
presence of different long-range interactions which are likely
already altered in non-calcium bound forms of the familial
mutants and upon the addition of PO42− at S129 (Fig. 7). Cal-
cium binding leads to further disruption of intramolecular
interactions with the C-terminus leading to unfolding and solvent
exposure of the N-terminus.
The extent of N-terminus solvent exposure upon disruption of
contacts with the C-terminus when calcium binds correlates with
the aggregation propensity of aSyn; pS129, A53E, and to some
extent D121A aSyn, were less solvent exposed at the N-terminus
and had a reduced aggregation propensity compared to WT and
A53T aSyn which were more aggregation prone and more solvent
exposed at the N-terminus and at the beginning of the NAC
Fig. 6 HDX-MS reveals different conformations in A53E compared to WT and A53T aSyn. Bars represent differences in deuterium uptake of peptides
along the sequence of differently compared aSyn mutants with the N-terminus region in blue, the NAC region in yellow, and the C-terminus in red.
Negative values represent increased deuterium uptake in the mutant (a–c) or in the calcium bound state (d–f), correlating to more solvent exposure, and
less hydrogen bonding. The start and end of each peptide is marked on the x-axis (from aSyn peptide map see Supplementary Fig. 11). Peptides containing
the mutation were not comparable to WT aSyn and were removed from the data set, indicated by blank regions. Difference in deuterium uptake (Da)
between a WT and A53T aSyn, b WT and A53E aSyn and c A53T and A53E aSyn showed no significant differences throughout the sequence. In the
presence of calcium, as previously shown in Fig. 2c, dWT aSyn becomes significantly deprotected at the N-terminus and the NAC region, and more solvent
protected at the C-terminus. e Similarly, A53T aSyn is significantly deprotected at the N-terminus and the NAC region upon calcium addition, and at the
same time becomes solvent protected at the C-terminus. f A53E aSyn also becomes solvent protected at the C-terminus upon calcium addition but no
significant changes are observed at the NAC region and most of the N-terminus. The grey trace signifies the error (1 s.d.) of six replicates collected per
condition. Data acquired at each peptide were subjected to an unpaired Student’s t-test with alpha set to 1%. Each row was analysed individually, without
assuming a consistent SD, individual two-tailed p values are presented in Supplementary Tables 1–5 and significant differences where p-values are ≤0.01
are presented by a *. Individual replicate values for deuterium uptake are presented in Supplementary Figs. 25–27.
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region (Fig. 7). It remains to be determined whether these dif-
ferent structures of monomeric aSyn can be isolated, potentially
by cross-linking to stabilise structures, or whether they have
different toxicity in cells. Furthermore, it would be interesting to
investigate whether these conformational changes and exposure
of the N-terminus lead to a reduction of the energy barrier
needed to be overcome for dimer formation, which may be
crucial in determining whether aSyn becomes pathological or not.
This would be an important step in rationalising the molecular
mechanism of PD and other synucleinopathies by identifying
which local environmental factors bias the monomeric population
towards the most disease-relevant conformers. Finally, targeting
the most disease-relevant monomeric structures of aSyn and to
convert them into ‘normal’ functional structures could open up a
new chapter in the design of therapeutics against PD and other
synucleinopathies.
Methods
Purification of aSyn. Human wild-type (WT) alpha-synuclein was expressed using
plasmid pT7-7. aSyn mutations D115A, D119A, D121A, A30P, E46K, A53T, A53E,
H50Q and G51D were introduced using the QuikChange Lighting Site-Directed
Mutagenesis K (Agilent Technologies LDA UK Limited, UK), primer list is
Binding of calcium to aSyn C-terminus leads to different 
conformations dependent on PTM and sequence
Binding of calcium to WT
aSyn leads to exposure of
the N-terminusDynamic ensemble of aSyn
conformations
Binding of calcium to
pS129 aSyn leads to no
exposure of the N-terminus
Addition of PO42– group alters
intramolecular interactions
with the C-terminus
Binding of calcium to A53T
aSyn leads to exposure of the
N-terminus, while A53E has no
exposure of the N-terminus 
Presence of point mutation
alters intramolecular
interactions with the N-terminus
a
d
eb
c
f
Fig. 7 Cartoon representation of the effect of phosphorylation, mutation and calcium binding on aSyn. a aSyn is a dynamic ensemble of conformations in
solution. Its solubility is maintained by long-range interactions between the N-terminus (blue), NAC region (yellow) and the C-terminus (blue) of aSyn.
b Addition of a phosphate group to S129 (purple circle) or c a point mutation (teal cross) alters the long-range interactions and skews the dynamic
ensemble to favour or disfavour aggregation prone structures. d Addition of divalent cations such as calcium (green) leads to charge shielding and
exposure of the N-terminus of aSyn. e Calcium binding to phosphorylated aSyn leads to different perturbations of long-range interactions. Phosphorylation
at S129 leads to a slightly different calcium binding region and to reduced solvent exposure of the N-terminus compared to WT aSyn. f The aSyn mutation
A53T (blue with blue cross) leads to N-terminus solvent exposure upon calcium binding at the C-terminus, similar to WT aSyn, however, the aSyn
mutation A53E (light teal with teal cross) leads to less N-terminus solvent exposure upon calcium binding. Created with BioRender.com.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-16564-3 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:2820 | https://doi.org/10.1038/s41467-020-16564-3 | www.nature.com/naturecommunications 11
available on the Cambridge University Repository and Supplementary Table 13,
and confirmed by sequencing (Source Bioscience, Nottingham, UK). The plasmids
were heat shocked into Escherichia coli One Shot® BL21 STAR™ (DE3) (Invitrogen,
Thermo Fisher Scientific, Cheshire, UK) and protein expression induced with
isopropyl β-d-1-thiogalactopyranoside (IPTG). Recombinant aSyn was purified
using ion exchange chromatography (IEX) in buffer A (10 mM Tris, 1 mM EDTA
pH 8) against a linear gradient of buffer B (10 mM Tris, 1 mM EDTA, 0.5 M NaCl
pH 8) on a HiPrep Q FF 16/10 anion exchange column (GE Healthcare, Uppsala,
Sweden). aSyn was then dialysed into buffer C (1M (NH4)2SO4, 50 mM Bis-Tris
pH 7) and further purified on a HiPrep Phenyl FF 16/10 (High Sub) hydrophobic
interaction chromatography (HIC) column (GE Healthcare) and eluted against
buffer D (50 mM Bis-Tris pH 7). aSyn was extensively dialysed against 20 mM Tris
pH 7.2 and concentrated using 10 k MWCO amicon centrifugal filtration devices
(Merck KGaA, Darmstadt, Germany) and stored at −80 °C until use. Before
experiments 1 mL of aSyn was further purified using a Superdex 75 pg 10/300 GL
size exclusion chromatography (SEC) column (GE Healthcare) in 20 mM Tris
pH 7.2 to obtain monomeric protein. Purification was performed on an ÄKTA
Pure (GE Healthcare). Protein concentration was determined by measuring the
absorbance at 280 nm on a Nanovue spectrometer using the extinction coefficient
5960M−1cm−1.
Protein purity was analysed using analytical reversed phase chromatography.
Each purification batch was analysed using a Discovery BIO Wide Pore C18
column, 15 cm × 4.6 mm, 5 µm, column with a guard cartridge (Supelco by Sigma-
Aldrich) with a gradient of 95% to 5% H2O+ 0.1% trifluroacetic acid (TFA) and
acetonitrile+ 0.1% TFA at a flow-rate of 1 mL/min. The elution profile was
monitored by UV absorption at 220 nm and 280 nm on an Agilent 1260 Infinity
HPLC system (Agilent Technologies LDA UK Limited, UK) equipped with an
autosampler and a diode-array detector (a representative chromatograph is shown
in Supplementary Fig. 20a and a Coomassie blue stained SDS-PAGE gel of
monomeric pure aSyn in Fig. 20b). Protein purity fell between 89 and 96%. Figures
of the chromatographs were created in and exported from MatLab R2019a
(MathWorks, USA).
Purification of aSyn for nuclear magnetic resonance experiments. E. coli was
grown in isotope-enriched M9 minimal medium containing 15N ammonium
chloride, and 13C-glucose74. To isolate expressed aSyn the cell pellets were lysed by
sonication in 10 mM Tris, 200 μM EDTA, protease inhibitor tablets (cOmplete™,
EDTA-free, Roche) pH 8. The cell lysate was centrifuged at 20 k × g for 30 min and
the supernatant was then heated for 20 min at 90 °C to precipitate the heat-
sensitive proteins and subsequently centrifuged at 22 k × g for 30 min to remove
precipitated proteins. Streptomycin sulfate (Sigma-Aldrich) 10 mgml−1 was added
to the supernatant and incubated at RT for 15 min to precipitate DNA, the mixture
was centrifuged at 22 k × g for 30 min to remove DNA and then repeated.
Ammonium sulfate 360 mgml−1 was added to the supernatant and stirred for
30 min to precipitate the aSyn protein. The solution centrifuged at 22 k × g for
30 min and the resulting pellet was resuspended in 25 mM Tris-HCl, pH 7.7 and
dialysed overnight. The protein was purified by IEX, described above, then further
purified by SEC on a HiLoad 16/60 Superdex 75 prep grade column (GE
Healthcare) in 20 mM Tris pH 7.2. All the fractions containing the monomeric
protein were pooled together and concentrated by using 10 k MWCO centrifugal
filtration devices (Merck).
Purification of phosphorylated serine 129 aSyn. WT aSyn 13C/15N-labelled
(aSyn 13C/15N) was expressed and purified as previously described75,76. Briefly, E.
coli BL21(DE3) cells were transfected with a pT7-7 plasmid containing WT aSyn
and was cultured in an isotopically supplemented minimal media75, then aSyn 13C/
15N was purified using an anion exchange chromatography followed by reversed-
phase HPLC (RP-HPLC) purification using a Proto 300 C4 column and a gradient
from 30 to 60% B over 35 min at 15 ml/min, where solvent A was 0.1% TFA in
water and solvent B was 0.1% TFA in acetonitrile, the fractions containing the
protein were pooled and lyophilized and the protein was stored at −20 °C. For the
preparation of phosphorylated S129 aSyn 13C/15N (aSyn 13C/15N pS129), we used
a protocol using PLK3 kinase to introduce selectively the phosphorylation at
S12977. The WT aSyn 13C/15N was resuspended in the phosphorylation buffer
(50 mM HEPES, 1 mM MgCl2, 1 mM EGTA, 1 mM DTT) at a concentration of
∼150 µm and then 2 mM of ATP and 0.42 μg of PLK3 kinase (Invitrogen) per
500 μg of protein were added. The enzymatic reaction was left at 30 °C overnight
without shaking. Upon complete phosphorylation, as monitored by mass spec-
troscopy (LC/MS), aSyn 13C/15N pS129 was purified from the reaction mixture
by RP-HPLC using an Inertsil WP300–C8 semiprep column. Finally, the frac-
tions containing the protein of interest were pooled and quality control of aSyn
13C/15N pS129 was performed using mass spectroscopy, UPLC, and SDS-PAGE,
the protein was 99.89% phosphorylated (Supplementary Fig. 20c–e).
Solution nuclear magnetic resonance (NMR). In order to probe the structure
and thermodynamics of calcium binding with aSyn WT, pS129 and D121A at a
residue specific level, we employed a series of 1H-15N HSQC experiments using
different concentrations of Ca2+ (0.0 mM–4.2 mM) and a fixed concentration
of aSyn (200 μM). The pH of samples was checked before experiments were
performed and after calcium addition. NMR experiments were carried out at 10 °C
on a Bruker spectrometer operating at 1H frequencies of 800MHz equipped with
triple resonance HCN cryo-probe and data collected in the Topspin 3.6.0 software
(Bruker, AXS GmBH). The 1H-15N HSQC experiments were recorded using a data
matrix consisting of 2048 (t2, 1H) × 220 (t1, 15N) complex points. Assignments of
the resonances in 1H-15N-HSQC spectra of aSyn were derived from our previous
studies and data analysed using the Sparky 3.1 software.
The perturbation of the 1H-15N HSQC resonances was analysed using a
weighting function in Eq. 1:
Δδ ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
1
2
δ2H þ 0:15δ2N
 
r
ð1Þ
The titration enabled calculating the fraction of bound aSyn, χB, as a function of
[Ca2+].
χB ¼
Δδobs
Δδsat
ð2Þ
Where the Δδobs is the chemical shift perturbation of the amide group of a residue
of aSyn at a given [Ca2+] and Δδsat is the perturbation obtained with calcium
saturation. χB values were obtained as a function of [Ca2+] for every residue of the
protein for which resolved peaks in the 1H-15N HSQC are available. A global χB
was calculated by average the fractions corresponding to residues associated with
major resonance perturbations in the presence of calcium.
In order to obtain the apparent dissociation constant, we used two different
models.
As first, we employed a model based on previous investigations40:
αsynU þ Ca2þ L¼ αsynB Ca2þ
 
L ð3Þ
Where αsynU and αsynB indicate free and calcium bound aSyn, L indicates the
number of Ca2+ interacting with one aSyn molecule, and the overall concentration
of aSyn in this equilibrium is given by
αsyn½  ¼ αsynU þ αsynB Ca2þ L
  ð4Þ
the apparent dissociation constant in this model corresponds to:
KD ¼
αsynU½  Ca2þL
 
αsynB Ca2þð ÞL
  ð5Þ
Which provides a formula for χB:
χB ¼
αsyn½  þ Ca2þL
h i
þ KD 
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
αsyn½  þ Ca2þL
h i
þ KD
 2
 4 αsyn½  Ca2þ½ L
r
2 αsyn½ 
ð6Þ
When using this fitting model in the case of WT aSyn we obtained a KD of 21 (±5)
μM and an L of 7.8 (±0.51)40. Based on the present MS data, we here fixed the value
of L to 3.
We then used a different model that accounts for the cooperativity of the
binding. In particular, we used the Hill equation to fit our data in Eq. 7:
χB ¼
Ca2þ½ n
KD þ Ca2þ½ n
ð7Þ
Where the Hill coefficient, n, describes the cooperativity of the binding. A n value
higher than 1 indicates a positive cooperativity for the binding.
Hydrogen-deuterium exchange mass spectrometry (HDX-MS). Hydrogen
exchange was performed using an HDX Manager (Waters, USA) equipped with a
CTC PAL sample handling robot (LEAP Technologies, USA). Samples of aSyn
(10 μΜ) in protonated aqueous buffer (20mM Tris, pH 7.2) were diluted 20-fold into
deuterated buffer (20mM Tris, pD 7.2) at 20 °C, initiating hydrogen exchange. The
same was performed for the calcium condition, in protonated and deuterated buffers
containing 1mM CaCl2 (20mM Tris, pH 7.2, 1mM CaCl2, and 20mM Tris, pD 7.2,
1 mM CaCl2). Samples were pre-incubated in calcium containing buffer for 30min in
a aSyn:CaCl2 ratio of 1:100. The protein was then incubated for 30 s in the deuterated
buffer and six replicates were collected per condition. Hydrogen exchange was
arrested by mixing 1:1 with pre-chilled quench solution (100mM Tris, 8M Urea, pH
2.45 at 0 °C). The protein was then digested into peptides on a pepsin column
(Enzymate, Waters) and the peptides were separated on a C18 column (1 × 100mm
ACQUITY UPLC BEH 1.7 μm, Waters) with a linear gradient of acetonitrile (3–40%)
supplemented with 0.2% formic acid. Peptides were analysed with a Synapt G2-Si
mass spectrometer (Waters). The mass spectrometer was calibrated with NaI calibrant
in positive ion mode. Α clean blank injection was ran between samples to minimise
carry-over. Peptide mapping of aSyn, where peptides were identified by MS/MS
fragmentation, was performed prior to the hydrogen exchange experiments and
analysed using ProteinLynx Global Server- PLGS (Waters). Peptide mapping of aSyn
yielded coverage of 100% of aSyn with a high degree of redundancy (5.38) (Supple-
mentary Fig. 11). The following parameters were used to filter the quality of the
peptides: minimum and maximum peptide sequence length of 4 and 50, respectively,
minimum intensity of 5000, and minimum products per amino acid of 0.2. All spectra
generated from the peptides were examined and only peptides with high-quality
spectra and a high signal to noise ratio were used for data analysis. The data
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pertaining to deuterium uptake (representative data presented in Supplementary
Fig. 21 and all replicates presented in Supplementary Figs. 22–27) were analysed and
visualised in DynamX 3.0 (Waters) and GraphPad Prism 8 (GraphPad Software, US).
No correction was made for back-exchange. To allow access to the HDX data of this
study, the HDX data summary table is included in the supporting information as per
consensus guidelines78.
Thioflavin-T (ThT) based assays. 10 μM freshly made ThT (Abcam, Cambridge,
UK) was added to 50 μL of 10 μM aSyn in 20 mM Tris pH 7.2. All samples were
loaded onto nonbinding, clear bottom, 96-well half-area plates (Greiner Bio-One
GmbH, Germany). The plates were sealed with a SILVERseal aluminium micro-
plate sealer (Grenier Bio-One GmbH). Fluorescence measurements were taken
with a FLUOstar Omega plate reader (BMG LABTECH GmbH, Ortenbery, Ger-
many). The plates were incubated at 37 °C with orbital shaking at 300 rpm for five
minutes before each read every hour. Excitation was set at 440 nm with 20 flashes
and the ThT fluorescence intensity measured at 480 nm emission with a 1300 gain
setting. ThT assays were repeated at least 3 times using four or more wells for each
condition. Data were normalised to the well with the maximum fluorescence
intensity for each plate and the average fluorescence intensity was calculated for all
experiments in Microsoft Excel 2016 (Microsoft Office, Washington, USA). The lag
time (tlag) and half-life of the fluorescence (t50) were calculated for each aSyn
variant, also in Microsoft Excel. An unpaired two-tailed t-test, with a 95% con-
fidence interval, was used to calculate statistical significance between samples
before and after the addition of calcium using GraphPad Prism 8.
Analytical size exclusion chromatography (SEC). SEC-HPLC analysis was used
to calculate the remaining aSyn monomer concentration in each well at the end of
the ThT assays. The contents of each well after the ThT-based assay were cen-
trifuged at 21 k × g for 20min and the supernatant added to individual aliquots in
the autosampler of the Agilent 1260 Infinity HPLC system (Agilent Technologies
LDA UK Limited, UK). 35 μL of each sample was injected onto an Advance Bio SEC
column, 7.8 × 300mm 300Å (Agilent, UK) in 20 mM Tris pH 7.2 at 1 mLmin−1
flow-rate. The elution profile was monitored by UV absorption at 220 and 280 nm.
A calibration curve of known concentrations of aSyn was used to calculate the
remaining monomer concentration of aSyn in each well. Two or three wells per
experiment for three experiments were analysed for the remaining monomer con-
centration. Figures of the chromatographs were created in and exported from
MatLab R2019a (MathWorks, USA).
Nano electrospray ionisation mass spectrometry (Nano ESI-MS). A final
concentration of 20 µM aSyn (WT or mutant) was obtained in 20 mM ammonium
acetate (Sigma Aldrich, St. Louis, MO, USA) pH 7 and measured as a control.
CaCl2 (Merck, Darmstadt, Germany) was dissolved in deionised H2O and added to
the sample with a final concentration ranging between 200 µM and 400 µM. The
samples were incubated for 10 min at room temperature before measuring. Nano-
ESI mass spectrometry measurements were performed on a Synapt G2 HDMS
(Waters, Manchester, UK) and analysed using Masslynx version 4.1 (Waters,
Manchester, UK). For infusion into the mass spectrometer, home-made gold-
coated borosilicate capillaries were used. The main instrumental settings were:
capillary voltage 1.4–1.8 kV; sampling cone 25 V; extraction cone 1 V; trap CE 4 V;
transfer CE 0 V; trap bias 40 V. Gas pressures used throughout the instrument
were: source 1.5–2.7 mbar; trap cell 2.3 × 10−2 mbar; IM cell 3.0 mbar; transfer cell
2.5 × 10−2 mbar. Data were analysed and exported from Origin version 8 (Origin
Lab Corporation, Northampton, USA).
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this paper.
Data availability
Source data underlying Figs. 3, 4, 5, 6, Supplementary Figs. 1, 9, 11–15, 17–19, 21–27 are
provided as a Source data file. Other data sets associated with all figures are available
from the University of Cambridge Data Repository https://doi.org/10.17863/CAM.50622.
Additional figures and data for ThT-based kinetic assays, AFM data, NMR calcium
titration data, additional HDX-MS data, additional native MS data, all nano-ESI-IM-MS
data, purity of aSyn samples, Supplementary Methods and primer sequences are found in
the Supplementary Information.
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